Home/Filings/4/0000886163-22-000078
4//SEC Filing

Patel Sunil 4

Accession 0000886163-22-000078

CIK 0000886163other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 6:45 PM ET

Size

7.0 KB

Accession

0000886163-22-000078

Insider Transaction Report

Form 4
Period: 2022-06-10
Patel Sunil
Director
Transactions
  • Award

    Common Stock

    2022-06-10+1,00429,824 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-06-10+4,3404,340 total
    Exercise: $79.29Exp: 2032-06-10Common Stock (4,340 underlying)
Footnotes (2)
  • [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
  • [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001503062

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:45 PM ET
Size
7.0 KB